5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | BUY | BUY | BUY | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 6.91▲ | 6.94▲ | 6.95▼ | 6.60▲ | 6.36▲ |
MA10 | 6.92▲ | 6.95▼ | 6.88▲ | 6.36▲ | 5.48▲ |
MA20 | 6.93▲ | 6.86▲ | 6.76▲ | 6.11▲ | 5.71▲ |
MA50 | 6.97▼ | 6.66▲ | 6.49▲ | 5.16▲ | 7.20▼ |
MA100 | 6.84▲ | 6.44▲ | 6.23▲ | 5.83▲ | 10.08▼ |
MA200 | 6.69▲ | 6.19▲ | 5.72▲ | 6.78▲ | 16.19▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.000▼ | -0.010▼ | 0.008▲ | 0.055▲ | 0.330▲ |
RSI | 50.826▲ | 60.455▲ | 65.075▲ | 68.889▲ | 56.479▲ |
STOCH | 39.841 | 37.767 | 63.930 | 73.841 | 89.584▲ |
WILL %R | -25.000▲ | -41.379 | -36.641 | -15.789▲ | -6.434▲ |
CCI | 58.333 | 5.293 | 56.752 | 172.095▲ | 135.025▲ |
Friday, June 13, 2025 12:00 PM
NEWTOWN, PA — Helius Medical Technologies, Inc. (NASDAQ: HSDT) announced encouraging results from its PoNSTEP study, presented at the 2025 Consortium of Multiple Sclerosis Centers (CMSC) Annual ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
16/06/25 | 6.735 | 7.18 | 6.68 | 6.94 | 136,556 |
13/06/25 | 6.61 | 6.74 | 6.48 | 6.62 | 180,000 |
12/06/25 | 6.42 | 6.80 | 6.2853 | 6.76 | 188,970 |
11/06/25 | 6.24 | 6.55 | 6.17 | 6.52 | 309,913 |
10/06/25 | 6.19 | 6.28 | 6.115 | 6.16 | 61,754 |
09/06/25 | 6.57 | 6.68 | 6.14 | 6.14 | 197,565 |
06/06/25 | 6.16 | 6.56 | 6.09 | 6.49 | 204,100 |
05/06/25 | 6.01 | 6.12 | 5.94 | 6.00 | 172,500 |
04/06/25 | 6.04 | 6.08 | 5.85 | 5.99 | 288,900 |
03/06/25 | 5.77 | 6.07 | 5.66 | 6.00 | 221,700 |
|
|
||||
|
|
||||
|
|